NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.95 Million USD | 1040.65% |
| 2022 | 171.16 Thousand USD | -3.92% |
| 2021 | 178.14 Thousand USD | -90.75% |
| 2020 | 1.92 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 742.00 USD | -4.01% |
| 2014 | 773.00 USD | -38.11% |
| 2013 | 1249.00 USD | 35.61% |
| 2012 | 921.00 USD | -82.94% |
| 2011 | 5398.00 USD | 362.55% |
| 2010 | 1167.00 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.37 Million USD | 40.88% |
| 2024 Q3 | 825.77 Thousand USD | -40.04% |
| 2024 Q1 | 977.64 Thousand USD | 31.8% |
| 2023 Q2 | 466.17 Thousand USD | 306.86% |
| 2023 FY | 1.95 Million USD | 1040.65% |
| 2023 Q4 | 741.78 Thousand USD | 17.76% |
| 2023 Q1 | 114.57 Thousand USD | 66.57% |
| 2023 Q3 | 629.9 Thousand USD | 35.12% |
| 2022 Q3 | 32.04 Thousand USD | -12.4% |
| 2022 FY | 171.16 Thousand USD | -3.92% |
| 2022 Q4 | 68.78 Thousand USD | 114.63% |
| 2022 Q2 | 36.58 Thousand USD | 8.4% |
| 2022 Q1 | 33.74 Thousand USD | -30.18% |
| 2021 Q4 | 48.33 Thousand USD | 20.55% |
| 2021 FY | 178.14 Thousand USD | -90.75% |
| 2021 Q1 | 71.47 Thousand USD | -96.29% |
| 2021 Q2 | 18.24 Thousand USD | -74.48% |
| 2021 Q3 | 40.09 Thousand USD | 119.82% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | 1.92 Million USD | 0.0% |
| 2020 Q4 | 1.92 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q1 | 281.00 USD | 485.42% |
| 2016 Q2 | 102.00 USD | -63.7% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 FY | - USD | -100.0% |
| 2015 FY | 742.00 USD | -4.01% |
| 2015 Q4 | 48.00 USD | -84.0% |
| 2015 Q3 | 300.00 USD | 165.49% |
| 2015 Q2 | 113.00 USD | -31.93% |
| 2015 Q1 | 166.00 USD | 19.42% |
| 2014 Q3 | 303.00 USD | 83.64% |
| 2014 Q2 | 165.00 USD | 17.86% |
| 2014 Q1 | 140.00 USD | -44.44% |
| 2014 FY | 773.00 USD | -38.11% |
| 2014 Q4 | 139.00 USD | -54.13% |
| 2013 Q2 | 406.00 USD | 12.78% |
| 2013 Q4 | 252.00 USD | -44.12% |
| 2013 Q3 | 451.00 USD | 11.08% |
| 2013 FY | 1249.00 USD | 35.61% |
| 2013 Q1 | 360.00 USD | 1465.22% |
| 2012 Q1 | 297.00 USD | -63.42% |
| 2012 Q3 | 391.00 USD | 165.99% |
| 2012 Q4 | 23.00 USD | -94.12% |
| 2012 FY | 921.00 USD | -82.94% |
| 2012 Q2 | 147.00 USD | -50.51% |
| 2011 Q3 | 1218.00 USD | -60.34% |
| 2011 Q4 | 812.00 USD | -33.33% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q2 | 3071.00 USD | 0.0% |
| 2011 FY | 5398.00 USD | 362.55% |
| 2010 Q3 | 398.00 USD | 0.0% |
| 2010 FY | 1167.00 USD | 0.0% |
| 2010 Q4 | 273.00 USD | -31.41% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 72.746% |
| Cerus Corporation | 156.36 Million USD | 98.751% |
| OrthoPediatrics Corp. | 148.73 Million USD | 98.687% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -101.551% |
| Talis Biomedical Corporation | 412 Thousand USD | -373.893% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 85.853% |
| Inogen, Inc. | 315.66 Million USD | 99.381% |
| Spectral AI, Inc. | 18.05 Million USD | 89.187% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 80.288% |
| CVRx, Inc. | 39.29 Million USD | 95.031% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -203.174% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.739% |
| Venus Concept Inc. | 76.35 Million USD | 97.443% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 83.809% |
| Bioventus Inc. | 512.34 Million USD | 99.619% |
| BrainsWay Ltd. | 31.78 Million USD | 93.857% |
| Envoy Medical, Inc. | 316 Thousand USD | -517.861% |
| electroCore, Inc. | 16.03 Million USD | 87.82% |
| IceCure Medical Ltd | 3.22 Million USD | 39.534% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 19.586% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -434.917% |
| MaxCyte, Inc. | 41.28 Million USD | 95.271% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1662.958% |
| PAVmed Inc | 2.45 Million USD | 20.374% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 91.33% |
| RxSight, Inc. | 89.07 Million USD | 97.808% |
| Sight Sciences, Inc. | 81.05 Million USD | 97.591% |
| SI-BONE, Inc. | 138.88 Million USD | 98.594% |
| TELA Bio, Inc. | 58.45 Million USD | 96.66% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 89.453% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 98.957% |
| LivaNova PLC | 1.15 Billion USD | 99.831% |
| 908 Devices Inc. | 50.22 Million USD | 96.113% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.595% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -2434.19% |
| NeuroPace, Inc. | 65.42 Million USD | 97.016% |
| LENSAR, Inc. | 42.16 Million USD | 95.369% |
| Apyx Medical Corporation | 52.34 Million USD | 96.27% |
| Cutera, Inc. | 212.36 Million USD | 99.081% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 94.147% |
| BioSig Technologies, Inc. | 18 Thousand USD | -10746.894% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 98.829% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 91.85% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.873% |
| Axonics, Inc. | 366.37 Million USD | 99.467% |
| Outset Medical, Inc. | 130.37 Million USD | 98.502% |
| IRIDEX Corporation | 51.86 Million USD | 96.236% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 98.566% |
| IRadimed Corporation | 65.56 Million USD | 97.022% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -66.024% |
| INVO Bioscience, Inc. | 3.02 Million USD | 35.362% |
| Telesis Bio, Inc. | 27.5 Million USD | 92.903% |
| Viemed Healthcare, Inc. | 183 Million USD | 98.933% |
| Varex Imaging Corporation | 811 Million USD | 99.759% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.119% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 97.157% |
| Dynatronics Corporation | 32.53 Million USD | 93.999% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 77.501% |
| Semler Scientific, Inc. | 68.18 Million USD | 97.137% |
| InMode Ltd. | 492.04 Million USD | 99.603% |
| Bruker Corporation | 2.96 Billion USD | 99.934% |
| Cytosorbents Corporation | 36.34 Million USD | 94.629% |
| DexCom, Inc. | 3.62 Billion USD | 99.946% |
| Align Technology, Inc. | 3.86 Billion USD | 99.949% |
| Viveve Medical, Inc. | 6.42 Million USD | 69.617% |
| ZimVie Inc. | 457.43 Million USD | 99.573% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 98.988% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1662.958% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.739% |
| Profound Medical Corp. | 7.33 Million USD | 73.367% |
| Insulet Corporation | 1.69 Billion USD | 99.885% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 98.451% |
| iCAD, Inc. | 17.31 Million USD | 88.726% |
| Nuwellis, Inc. | 8.86 Million USD | 77.973% |
| Biotricity, Inc. | 12.06 Million USD | 83.815% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.604% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 68.534% |
| PAVmed Inc. | 2.45 Million USD | 20.374% |
| BIOLASE, Inc. | 49.16 Million USD | 96.029% |
| Beyond Air, Inc. | 1.15 Million USD | -68.459% |
| FONAR Corporation | 102.88 Million USD | 98.102% |
| AxoGen, Inc. | 159.01 Million USD | 98.772% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.289% |
| Inari Medical, Inc. | 493.63 Million USD | 99.604% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.512% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -10396.995% |
| Tenon Medical, Inc. | 2.92 Million USD | 33.318% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 71.338% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.939% |
| Sintx Technologies, Inc. | 2.62 Million USD | 25.678% |
| NanoVibronix, Inc. | 2.28 Million USD | 14.479% |
| Quanterix Corporation | 122.36 Million USD | 98.404% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 92.0% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.026% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.192% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 85.907% |
| NeuroMetrix, Inc. | 5.9 Million USD | 66.916% |
| Hyperfine, Inc. | 11.03 Million USD | 82.302% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 98.818% |
| Biomerica, Inc. | 5.41 Million USD | 63.944% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 96.138% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 98.898% |